Stem Cell Therapy Market Outlook Report 2024-2033 | Size, Trends, Analysis, Insights, Overview

The Stem Cell Therapy by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Stem Cell Therapy Market:
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

According to The Business Research Company’s Stem Cell Therapy, The stem cell therapy market size has grown exponentially in recent years. It will grow from $6.43 billion in 2023 to $7.94 billion in 2024 at a compound annual growth rate (CAGR) of 23.5%.  The  growth in the historic period can be attributed to rising prevalence of chronic diseases, a rise in funding from governments and private organizations, rapid growth in emerging markets, an increase in investments in cell and gene therapies, surge in healthcare expenditure, and an increase in pharmaceutical r&d expenditure.

The stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $13.12 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%.  The growth in the forecast period can be attributed to increasing government support, rapid increase in the aging population, rising research and development spending, and increasing healthcare expenditure. Major trends in the forecast period include focus on closely monitoring advances in mesenchymal stem cells therapy with a view to capitalizing on innovations in the field, market players should collaborate with, and acquire other companies to further advance product innovation and to drive revenues, companies should consider investing in developing of ipsc-derived nk cells to treat patients, companies operating in the stem cell therapy market should concentrate on developing stem cell therapy, especially for cancer to gain a competitive advantage over somatic cell competitors, and companies operating in the stem cell therapy market should make use of artificial intelligence to improve product quality, safety and manufacturing productivity.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Top Major Players:
Smith & Nephew PLC
Fujifilm Holding Corporation
Thermo Fisher Scientific Inc
Takara Bio Inc.
MEDIPOST Co.

North America was the largest region in the stem cell therapy market in 2023.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in May 2022, SQZ Biotechnologies, a US-based biotechnology company partnered with STEMCELL Technologies Inc., a Canada-based biotechnology company to develop and commercialize a research-use-only (RUO) microfluidic intracellular delivery system, based on SQZ’s Cell Squeeze technology, providing the life sciences community with enhanced cell engineering capabilities for preclinical research. Both companies will present significant findings about the potential of the RUO system in efficiently delivering cargoes to primary immune cell types and demonstrating advancements in cell engineering with mRNA and CRISPR/Cas9 in hematopoietic stem cells.

The stem cell therapy market report table of contents includes:

1. Executive Summary
2. Stem Cell Therapy Market Characteristics
3. Stem Cell Therapy Market Trends And Strategies
4. Stem Cell Therapy Market – Macro Economic Scenario
5. Global Stem Cell Therapy Market Size and Growth
…
32. Global Stem Cell Therapy Market Competitive Benchmarking
33. Global Stem Cell Therapy Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Stem Cell Therapy Market
35.Stem Cell Therapy Market Future Outlook and Potential Analysis
36. Appendix

 Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model